Seshu Tyagarajan - Net Worth and Insider Trading

Seshu Tyagarajan Net Worth

The estimated net worth of Seshu Tyagarajan is at least $796,697 dollars as of 2024-10-30. Seshu Tyagarajan is the Chief Technology Officer of Candel Therapeutics Inc and owns about 146,049 shares of Candel Therapeutics Inc (CADL) stock worth over $796,697. Details can be seen in Seshu Tyagarajan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seshu Tyagarajan has not made any transactions after 2024-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Seshu Tyagarajan

To

Seshu Tyagarajan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Seshu Tyagarajan owns 1 companies in total, including Candel Therapeutics Inc (CADL) .

Click here to see the complete history of Seshu Tyagarajan’s form 4 insider trades.

Insider Ownership Summary of Seshu Tyagarajan

Ticker Comapny Transaction Date Type of Owner
CADL Candel Therapeutics Inc 2024-07-17 See Remarks

Seshu Tyagarajan Latest Holdings Summary

Seshu Tyagarajan currently owns a total of 1 stock. Seshu Tyagarajan owns 146,049 shares of Candel Therapeutics Inc (CADL) as of July 17, 2024, with a value of $796,697.

Latest Holdings of Seshu Tyagarajan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CADL Candel Therapeutics Inc 2024-07-17 146,049 5.46 796,697

Holding Weightings of Seshu Tyagarajan


Seshu Tyagarajan Form 4 Trading Tracker

According to the SEC Form 4 filings, Seshu Tyagarajan has made a total of 3 transactions in Candel Therapeutics Inc (CADL) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Candel Therapeutics Inc is the sale of 14,851 shares on July 17, 2024, which brought Seshu Tyagarajan around $96,086.

Insider Trading History of Seshu Tyagarajan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Seshu Tyagarajan Trading Performance

GuruFocus tracks the stock performance after each of Seshu Tyagarajan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seshu Tyagarajan is -16.27%. GuruFocus also compares Seshu Tyagarajan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seshu Tyagarajan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Seshu Tyagarajan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Seshu Tyagarajan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.26 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.19 LIMIT LIMIT LIMIT LIMIT LIMIT

Seshu Tyagarajan Ownership Network

Ownership Network List of Seshu Tyagarajan

No Data

Ownership Network Relation of Seshu Tyagarajan

Insider Network Chart

Seshu Tyagarajan Owned Company Details

What does Candel Therapeutics Inc do?

Who are the key executives at Candel Therapeutics Inc?

Seshu Tyagarajan is the See Remarks of Candel Therapeutics Inc. Other key executives at Candel Therapeutics Inc include director & Chief Scientific Officer Estuardo Aguilar-cordova , Chief Medical Officer William Garrett Nichols , and Chief Scientific Officer Francesca Barone .

Candel Therapeutics Inc (CADL) Insider Trades Summary

Over the past 18 months, Seshu Tyagarajan made 2 insider transaction in Candel Therapeutics Inc (CADL) with a net sale of 28,181. Other recent insider transactions involving Candel Therapeutics Inc (CADL) include a net sale of 75,414 shares made by Estuardo Aguilar-cordova , a net sale of 42,821 shares made by Paul Peter Tak , and a net sale of 26,696 shares made by Francesca Barone .

In summary, during the past 3 months, insiders sold 75,414 shares of Candel Therapeutics Inc (CADL) in total and bought 0 shares, with a net sale of 75,414 shares. During the past 18 months, 212,537 shares of Candel Therapeutics Inc (CADL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 212,537 shares.

Candel Therapeutics Inc (CADL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Candel Therapeutics Inc Insider Transactions

No Available Data

Seshu Tyagarajan Mailing Address

Above is the net worth, insider trading, and ownership report for Seshu Tyagarajan. You might contact Seshu Tyagarajan via mailing address: Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham Ma 02494.